Abiopharma

🔍 Amin Avinash (Executive)

Company: Neuronetics, Inc. (STIM)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 2,934 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: J | equity_swap_involved: false | shares_owned_after: 69,566.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 34,932 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: J | equity_swap_involved: false | shares_owned_after: 34,634.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 4,634 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: J | equity_swap_involved: false | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration.
• F2: Represents shares of common stock transferred to Health Partners.
• F3: Represents shares of common stock transferred to Cayman Master.
• F4: Represents shares of common stock transferred to Select Opportunities.